Teruo Kyoto Oku

This inventor holds 88 USPTO granted patents, primarily in Pharmaceutical Compounds (CPC class 424246). Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1976-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruo Kyoto Oku. Retrieved from https://idiyas.com/inventor/teruo-kyoto-oku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 88

% Patents Active = 95.5

Average Co-Inventor Count = 5.6

ph-index = 19

Forward Citations = 1,132(Granted Patents)

Forward Citations (Not Self Cited) = 1,087(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Kyoto, JA (1976 - 1978)
Osaka, JA (1978)
Shinmachi, JP (1981)
Mishima, JP (1987)
Kyoto, JP (1978 - 1990)
Sakuramura, JP (1990)
Ibaraki, JP (1988 - 1999)
Tsukuba, JP (1990 - 2002)
Takatsuki, JP (2001 - 2002)
late of Tokyo, JP (2002 - 2003)
Osaka, JP (1980 - 2005)

Company Filing History:

88 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

Years Active: 1976-2005

Loading Chart...

Areas of Expertise:

Sulfonamide Compounds

Benzamide Derivatives

Piperazine Compounds

Benzimidazole Derivatives

Bradykinin Antagonists

Heterocyclic Compounds

Quinoline Derivatives

Indole Derivatives

Pyrazole Derivatives

Angiotensin II Antagonists

Pharmaceutical Use

Inhibitors

88 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6911469 - Sulfonamide compounds and pharmaceutical use thereof (2005-06-28),

2. 6573274 - Sulfonamide compounds and uses thereof as medicines (2003-06-03),

3. 6495542 - Benzamide derivatives as vasopressin antagonists (2002-12-17),

4. 6489324 - Piperazine compounds as inhibitors of MMP or TNF (2002-12-03),

5. 6420409 - Benzimidazole derivatives (2002-07-16),

6. 6384080 - Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase (2002-05-07),

7. 6352985 - Benzimidazole compounds (2002-03-05),

8. 6348474 - Sulfonamide compounds and medicinal use thereof (2002-02-19),

9. 6344462 - Heterocyclic compounds as bradykinin antagonists (2002-02-05),

10. 6333324 - Piperazine compounds as inhibitors of MMP or TNF (2001-12-25),

11. 6316482 - Benzamide derivatives having a vasopressin antagonistic activity (2001-11-13),

12. 6207693 - Benzamide derivatives having a vasopressin antagonistic activity (2001-03-27),

13. 6194396 - Benzimidazole compounds as bradykinin antagonists (2001-02-27),

14. 6169095 - Bradykinin antagonist quinolines (2001-01-02),

15. 6166219 - Benzimidazole derivatives (2000-12-26),

Title: The Innovative Mind of Teruo Kyoto Oku

Introduction: Teruo Kyoto Oku, a visionary inventor hailing from Osaka, Japan, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Teruo Kyoto Oku's latest patents include cutting-edge technologies in the fields of robotics, artificial intelligence, and renewable energy, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over three decades, Teruo Kyoto Oku has established himself as a pioneer in the tech industry, holding numerous patents that have revolutionized various sectors. His relentless pursuit of innovation has led to the development of products that have improved the lives of many.

Collaborations: Throughout his career, Teruo Kyoto Oku has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: Teruo Kyoto Oku's passion for innovation, coupled with his exceptional talent for inventing, has solidified his reputation as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]